We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
CSIRO was the first research organization outside of China to generate sufficient stock of the virus to enable pre-clinical studies of COVID-19. Read More
Genetic Signatures said that running the assay on its fastest instruments can produce results for up to 188 patient samples in approximately 4.5 hours. Read More
The company said that it suspended its exclusivity to enable a greater supply of the drug should additional trials or evaluations show it has potential in treating COVID-19. Read More
“Our test will provide a highly accessible means for healthcare professionals to access laboratory quality results close in their office to aid in the decision to isolate, treat or dismiss potential carriers,” the San Diego company said. Read More